HUMAN SERUM AMYLOID-A3 ANTIBODY AND USE THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120189636A1
SERIAL NO

13499781

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Calculated Rating
US Family Size
Non-US Coverage

Abstract

See full text

The objective of the invention is to prepare an antibody to human SAA3 whose in vivo presence has not yet been identified in humans, thereby revealing the presence of in vivo human SAA3 and the relationship between human SAA3 and disease, and also to provide a method for treating such disease. More specifically our objective is to create an antibody to counter human serum amyloid-A3 and a kit for detecting and measuring human serum amyloid-A3 employing the aforementioned antibody, as well as a therapeutic cancer agent that can be utilized in methods to treat and diagnose cancer.

First Claim

See full text

Other Claims data not available

Family

PCTEP
+

Patent Owner(s)

Patent OwnerAddress
TOKYO WOMEN'S MEDICAL UNIVERSITYTOKYO 162-8666

International Classification(s)

loading....
  • 2010 Application Filing Year
  • A61K Class
  • 10962 Applications Filed
  • 7633 Patents Issued To-Date
  • 69.64 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances2010201120122013201420152016201720182019202020212022202320240255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Maru, Yoshiro Tokyo, JP 2 0
Tanaka, Takeshi Tokyo, JP 347 3882
Terai, Kiyomi Saitama, JP 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 0 Citation Count
  • A61K Class
  • 0 % this patent is cited more than
  • 13 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges842417611114322011046329171032401 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +0250500750100012501500175020002250250027503000325035003750400042504500

Forward Cite Landscape

Load Citation